Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli.

Antimicrobial agents and chemotherapy - 1 Mar 2015

Thulin Elisabeth, Sundqvist Martin, Andersson Dan I

Abstract excerpt

Amdinocillin (mecillinam) is a β-lactam antibiotic that is used mainly for the treatment of uncomplicated urinary tract infections. The objectives of this study were to identify mutations that confer amdinocillin resistance on laboratory-isolated mutants and clinical isolates of Escherichia coli and to determine why amdinocillin resistance remains rare clinically even though resistance is easily selected in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Bacterial Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Escherichia coli

Share to Escherichia coli research studies

Share to Laboratories

Share to Mutation

Share to Urinary Tract Infections Management

Source

Open in PubMed Open full text

Identifiers

PMID: 25583718
DOI: 10.1128/AAC.04819-14
PMCID: PMC4325821

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli.PMID 25583718Read ↗

Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.Semantic proximity Read ↗

Mechanisms and fitness costs of tigecycline resistance in Escherichia coli.Semantic proximity Read ↗

Chromosomal ampC mutations in cefpodoxime-resistant, ESBL-negative uropathogenic Escherichia coli.Semantic proximity Read ↗

Effect of Environment on the Evolutionary Trajectories and Growth Characteristics of Antibiotic-Resistant Escherichia coli MutantsSemantic proximity Read ↗

Hitchhiking genes and boundaries of AmpC amplicons during amoxicillin resistance development in E. coli.Semantic proximity Read ↗

Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.Semantic proximity Read ↗

Identification of a novel G2073A mutation in 23S rRNA in amphenicol-selected mutants of Campylobacter jejuni.Semantic proximity Read ↗

A novel hemA mutation is responsible for a small-colony-variant phenotype in Escherichia coli.Semantic proximity Read ↗

Characterization of mutations contributing to sulfathiazole resistance in Escherichia coli.Semantic proximity Read ↗

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli.Semantic proximity Read ↗

Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.Semantic proximity Read ↗

Piperacillin/tazobactam selects an ampC derepressed E. cloacae complex mutant in a diabetic osteoarticular infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.